{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:27:01Z","timestamp":1792132021938,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Research Foundation of Korea (NRF) grant funded by the Korean government","award":["NRF-2022R1A2C1009234"],"award-info":[{"award-number":["NRF-2022R1A2C1009234"]}]},{"name":"Seoul National University Bundang Hospital (SNUBH) Research Fund","award":["14-2023-0005"],"award-info":[{"award-number":["14-2023-0005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00271-4","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:46:33Z","timestamp":1747716393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Toxoplasma GRA16 attenuates Tau hyperphosphorylation and enhances autophagy in thrombin-treated HT-22 hippocampal neuronal cells"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8645-1966","authenticated-orcid":false,"given":"Seung-Hwan","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6877-0568","authenticated-orcid":false,"given":"Do-Won","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4251-7442","authenticated-orcid":false,"given":"Ji-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1215-1079","authenticated-orcid":false,"given":"Eun-Hee","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"271_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.25122\/jml-2022-0111","volume":"16","author":"VA Ciurea","year":"2023","unstructured":"Ciurea, V. A. et al. Alzheimer\u2019s disease: 120 years of research and progress. J. Med. Life. 16, 173\u2013177 (2023).","journal-title":"J. Med. Life"},{"key":"271_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA Deture","year":"2019","unstructured":"Deture, M. A. et al. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol. Neurodegener. 14, 32 (2019).","journal-title":"Mol. Neurodegener"},{"key":"271_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J. Neuroinflammation. 20, 165 (2023).","journal-title":"J. Neuroinflammation"},{"key":"271_CR4","doi-asserted-by":"publisher","first-page":"103487","DOI":"10.1016\/j.drudis.2023.103487","volume":"28","author":"KBE Moore","year":"2023","unstructured":"Moore, K. B. E. et al. Hyperphosphorylated Tau (p-tau) and drug discovery in the context of Alzheimer\u2019s disease and related Tauopathies. Drug Discov Today. 28, 103487 (2023).","journal-title":"Drug Discov Today"},{"key":"271_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bj.2018.01.003","volume":"41","author":"C Laurent","year":"2018","unstructured":"Laurent, C. et al. Tau and neuroinflammation: what impact for Alzheimer\u2019s disease and tauopathies? Biomed. J. 41, 21\u201333 (2018).","journal-title":"Biomed. J."},{"key":"271_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fneur.2013.00083","volume":"4","author":"W Noble","year":"2013","unstructured":"Noble, W. et al. The importance of Tau phosphorylation for neurodegenerative diseases. Front. Neurol. 4, 83 (2013).","journal-title":"Front. Neurol."},{"key":"271_CR7","doi-asserted-by":"publisher","first-page":"37681","DOI":"10.1074\/jbc.M301406200","volume":"278","author":"Z Suo","year":"2003","unstructured":"Suo, Z. et al. Rapid Tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling. J. Biol. Chem. 278, 37681\u201337689 (2003).","journal-title":"J. Biol. Chem."},{"key":"271_CR8","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/cells12091222","volume":"12","author":"J Iannucci","year":"2023","unstructured":"Iannucci, J. et al. Thrombin, a key driver of pathological inflammation in the brain. Cells 12, 1222 (2023).","journal-title":"Cells"},{"key":"271_CR9","first-page":"100014","volume":"2","author":"SW Bihaqi","year":"2021","unstructured":"Bihaqi, S. W. et al. Dabigatran reduces thrombin-induced neuroinflammation and AD markers in vitro: therapeutic relevance for Alzheimer\u2019s disease. Cereb. Circ. - Cogn. Behav. 2, 100014 (2021).","journal-title":"Cereb. Circ. - Cogn. Behav."},{"key":"271_CR10","doi-asserted-by":"publisher","first-page":"101464","DOI":"10.1016\/j.arr.2021.101464","volume":"72","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. Autophagy in Alzheimer\u2019s disease pathogenesis: therapeutic potential and future perspectives. Ageing Res. Rev. 72, 101464 (2021).","journal-title":"Ageing Res. Rev."},{"key":"271_CR11","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1038\/s41467-020-16984-1","volume":"11","author":"MC Silva","year":"2020","unstructured":"Silva, M. C. et al. Prolonged Tau clearance and stress vulnerability rescue by Pharmacological activation of autophagy in Tauopathy neurons. Nat. Commun. 11, 3258 (2020).","journal-title":"Nat. Commun."},{"key":"271_CR12","doi-asserted-by":"publisher","first-page":"1022821","DOI":"10.3389\/fnagi.2022.1022821","volume":"14","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. The emerging role of autophagy and mitophagy in tauopathies: from pathogenesis to translational implications in Alzheimer\u2019s disease. Front. Aging Neurosci. 14, 1022821 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"271_CR13","doi-asserted-by":"publisher","first-page":"1322842","DOI":"10.3389\/fimmu.2024.1322842","volume":"15","author":"I Bai","year":"2024","unstructured":"Bai, I. et al. Epigenetic regulation of autophagy in neuroinflammation and synaptic plasticity. Front. Immunol. 15, 1322842 (2024).","journal-title":"Front. Immunol."},{"key":"271_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-020-0358-9","volume":"15","author":"T Williams","year":"2020","unstructured":"Williams, T. et al. Therapeutic approaches targeting Apolipoprotein E function in Alzheimer\u2019s disease. Mol. Neurodegener. 15, 1\u201319 (2020).","journal-title":"Mol. Neurodegener"},{"key":"271_CR15","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/j.1471-4159.2007.04831.x","volume":"103","author":"B Maloney","year":"2007","unstructured":"Maloney, B. et al. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer\u2019s disease. J. Neurochem. 103, 1237\u20131257 (2007).","journal-title":"J. Neurochem"},{"key":"271_CR16","doi-asserted-by":"publisher","first-page":"17604","DOI":"10.1038\/s41598-021-97117-6","volume":"11","author":"HY Sohn","year":"2021","unstructured":"Sohn, H. Y. et al. ApoE4 attenuates autophagy via FoxO3a repression in the brain. Sci. Rep. 11, 17604 (2021).","journal-title":"Sci. Rep."},{"key":"271_CR17","doi-asserted-by":"crossref","unstructured":"Liu, Q. Q. et al. The role of Foxo3a in neuron-mediated cognitive impairment. Front. Mol. Neurosci. 17 (2024).","DOI":"10.3389\/fnmol.2024.1424561"},{"key":"271_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.chom.2013.03.002","volume":"13","author":"A Bougdour","year":"2013","unstructured":"Bougdour, A. et al. Host cell subversion by Toxoplasma gra16, an exported dense granule protein that targets the host cell nucleus and alters gene expression. Cell. Host Microbe. 13, 489\u2013500 (2013).","journal-title":"Cell. Host Microbe"},{"key":"271_CR19","doi-asserted-by":"crossref","unstructured":"Lu, X. X. et al. PTEN inhibits cell proliferation, promotes cell apoptosis, and induces cell cycle arrest via downregulating the PI3K\/AKT\/hTERTPathway in lung adenocarcinoma A549 cells. BioMed Res. Int. 2016, 2476842 (2016).","DOI":"10.1155\/2016\/2476842"},{"key":"271_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41392-022-01038-3","volume":"7","author":"J Pan","year":"2022","unstructured":"Pan, J. et al. Targeting protein phosphatases for the treatment of inflammation-related diseases: from signaling to therapy. Signal. Transduct. Target. Ther. 7, 177 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"271_CR21","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1111\/jcmm.14207","volume":"23","author":"SG Kim","year":"2019","unstructured":"Kim, S. G. et al. Increase in the nuclear localization of PTEN by the Toxoplasma GRA16 protein and subsequent induction of p53-dependent apoptosis and anticancer effect. J. Cell. Mol. Med. 23, 3234\u20133245 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"271_CR22","doi-asserted-by":"publisher","first-page":"6642","DOI":"10.3390\/ijms21186642","volume":"21","author":"SH Seo","year":"2020","unstructured":"Seo, S. H. et al. Toxoplasma GRA16 inhibits NF-\u03baB activation through PP2A-B55 upregulation in Non-Small-Cell lung carcinoma cells. Int. J. Mol. Sci. 21, 6642 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"271_CR23","doi-asserted-by":"publisher","first-page":"113366","DOI":"10.1016\/j.biopha.2022.113366","volume":"153","author":"SH Seo","year":"2022","unstructured":"Seo, S. H. et al. PTEN\/AKT signaling pathway related to hTERT downregulation and telomere shortening induced in Toxoplasma GRA16-expressing colorectal cancer cells. Biomed. Pharmacother. 153, 113366 (2022).","journal-title":"Biomed. Pharmacother"},{"key":"271_CR24","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.3390\/ijms23168972","volume":"23","author":"E Sun","year":"2022","unstructured":"Sun, E. et al. The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer\u2019s disease. Int. J. Mol. Sci. 23, 8972 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"271_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/ijms24010337","volume":"24","author":"B Calvo","year":"2022","unstructured":"Calvo, B. et al. GSK3\u03b2 Inhibition by phosphorylation at Ser389 controls neuroinflammation. Int. J. Mol. Sci. 24, 337 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"271_CR26","doi-asserted-by":"publisher","first-page":"108875","DOI":"10.1016\/j.celrep.2021.108875","volume":"34","author":"Y Han","year":"2021","unstructured":"Han, Y. et al. Roles of PINK1 in regulation of systemic growth Inhibition induced by mutations of PTEN in Drosophila. Cell. Rep. 34, 108875 (2021).","journal-title":"Cell. Rep."},{"key":"271_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fncel.2020.00019","volume":"14","author":"D Toral-Rios","year":"2020","unstructured":"Toral-Rios, D. et al. GSK3\u03b2 and Tau protein in Alzheimer\u2019s disease and epilepsy. Front. Cell. Neurosci. 14, 19 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"271_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40478-018-0557-6","volume":"6","author":"J Neddens","year":"2018","unstructured":"Neddens, J. et al. Phosphorylation of different Tau sites during progression of Alzheimer\u2019s disease. Acta Neuropathol. Commun. 6, 52 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"271_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fncel.2018.00338","volume":"12","author":"AD Alonso","year":"2018","unstructured":"Alonso, A. D. et al. Hyperphosphorylation of Tau associates with changes in its function beyond microtubule stability. Front. Cell. Neurosci. 12, 338 (2018).","journal-title":"Front. Cell. Neurosci."},{"key":"271_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13024-022-00521-3","volume":"17","author":"PJ Visser","year":"2022","unstructured":"Visser, P. J. et al. Cerebrospinal fluid Tau levels are associated with abnormal neuronal plasticity markers in Alzheimer\u2019s disease. Mol. Neurodegener. 17, 27 (2022).","journal-title":"Mol. Neurodegener"},{"key":"271_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12929-021-00774-y","volume":"28","author":"PC Pao","year":"2021","unstructured":"Pao, P. C. et al. Three decades of Cdk5. J. Biomed. Sci. 28, 79 (2021).","journal-title":"J. Biomed. Sci."},{"key":"271_CR32","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.molcel.2008.08.006","volume":"31","author":"Y Xu","year":"2008","unstructured":"Xu, Y. et al. Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Mol. Cell. 31, 873\u2013885 (2008).","journal-title":"Mol. Cell."},{"key":"271_CR33","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1096\/fj.06-5721fje","volume":"20","author":"X Zhang","year":"2006","unstructured":"Zhang, X. et al. Tumor suppressor PTEN affects Tau phosphorylation, aggregation, and binding to microtubules. FASEB J. 20, 1272\u20131274 (2006).","journal-title":"FASEB J."},{"key":"271_CR34","doi-asserted-by":"publisher","first-page":"BSR20181822","DOI":"10.1042\/BSR20181822","volume":"38","author":"X Lin","year":"2018","unstructured":"Lin, X. et al. Rapamycin inhibits proliferation and induces autophagy in human neuroblastoma cells. Biosci. Rep. 38, BSR20181822 (2018).","journal-title":"Biosci. Rep."},{"key":"271_CR35","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.tins.2012.06.004","volume":"35","author":"M D\u2019Amelio","year":"2012","unstructured":"D\u2019Amelio, M. et al. Caspase-3 in the central nervous system: beyond apoptosis. Trends Neurosci. 35, 700\u2013709 (2012).","journal-title":"Trends Neurosci."},{"key":"271_CR36","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"K Engeland","year":"2022","unstructured":"Engeland, K. Cell cycle regulation: p53-p21-RB signaling. Cell. Death Differ. 29, 946\u2013960 (2022).","journal-title":"Cell. Death Differ."},{"key":"271_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3347\/PHD.23129","volume":"62","author":"SH Seo","year":"2024","unstructured":"Seo, S. H. et al. Toxoplasma gondii IST suppresses inflammatory and apoptotic responses by inhibiting STAT1-mediated signaling in IFN-\u03b3\/TNF-\u03b1-stimulated hepatocytes. Parasites Hosts Dis. 62, 30\u201341 (2024).","journal-title":"Parasites Hosts Dis."},{"key":"271_CR38","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s13311-020-00957-9","volume":"18","author":"DW Ham","year":"2021","unstructured":"Ham, D. W. et al. Chronic Toxoplasma gondii infection alleviates experimental autoimmune encephalomyelitis by the immune regulation inducing reduction in IL-17A\/Th17 via upregulation of SOCS3. Neurother 18, 430\u2013447 (2021).","journal-title":"Neurother"},{"key":"271_CR39","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.3390\/ijms22052764","volume":"22","author":"JH Shin","year":"2021","unstructured":"Shin, J. H. et al. Reduction of amyloid burden by proliferated homeostatic microglia in Toxoplasma gondii-infected Alzheimer\u2019s disease model mice. Int. J. Mol. Sci. 22, 2764 (2021).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00271-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00271-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00271-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:46:37Z","timestamp":1747716397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00271-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["271"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00271-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5586914\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17412"}}